Advertisement
LLY vs MCK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLY is a Hold and MCK is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LLY’s FA Score shows that 2 FA rating(s) are green whileMCK’s FA Score has 3 green FA rating(s).
- LLY’s FA Score: 2 green, 3 red.
- MCK’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LLY’s TA Score shows that 5 TA indicator(s) are bullish while MCK’s TA Score has 4 bullish TA indicator(s).
- LLY’s TA Score: 5 bullish, 5 bearish.
- MCK’s TA Score: 4 bullish, 4 bearish.
Price Growth
LLY (@Pharmaceuticals: Major) experienced а -1.82% price change this week, while MCK (@Medical Distributors) price change was -0.37% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.
The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.
Reported Earning Dates
LLY is expected to report earnings on Oct 30, 2025.
MCK is expected to report earnings on Nov 04, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+1.13% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Medical Distributors (+2.01% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| LLY | MCK | LLY / MCK | |
| Capitalization | 740B | 70.5B | 1,050% |
| EBITDA | 8.57B | 4.44B | 193% |
| Gain YTD | 1.505 | 26.478 | 6% |
| P/E Ratio | 131.13 | 24.25 | 541% |
| Revenue | 34.1B | 302B | 11% |
| Total Cash | 2.93B | 1.98B | 148% |
| Total Debt | 25.2B | 7.61B | 331% |
LLY | MCK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 10 | 5 | |
SMR RATING 1..100 | 15 | 99 | |
PRICE GROWTH RATING 1..100 | 56 | 31 | |
P/E GROWTH RATING 1..100 | 96 | 48 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCK's Valuation (11) in the Medical Distributors industry is significantly better than the same rating for LLY (82) in the Pharmaceuticals Major industry. This means that MCK’s stock grew significantly faster than LLY’s over the last 12 months.
MCK's Profit vs Risk Rating (5) in the Medical Distributors industry is in the same range as LLY (10) in the Pharmaceuticals Major industry. This means that MCK’s stock grew similarly to LLY’s over the last 12 months.
LLY's SMR Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for MCK (99) in the Medical Distributors industry. This means that LLY’s stock grew significantly faster than MCK’s over the last 12 months.
MCK's Price Growth Rating (31) in the Medical Distributors industry is in the same range as LLY (56) in the Pharmaceuticals Major industry. This means that MCK’s stock grew similarly to LLY’s over the last 12 months.
MCK's P/E Growth Rating (48) in the Medical Distributors industry is somewhat better than the same rating for LLY (96) in the Pharmaceuticals Major industry. This means that MCK’s stock grew somewhat faster than LLY’s over the last 12 months.
| LLY | MCK | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 56% | N/A |
| Stochastic ODDS (%) | 4 days ago 71% | 4 days ago 47% |
| Momentum ODDS (%) | 4 days ago 53% | 4 days ago 45% |
| MACD ODDS (%) | 4 days ago 60% | 4 days ago 47% |
| TrendWeek ODDS (%) | 4 days ago 55% | 4 days ago 38% |
| TrendMonth ODDS (%) | 4 days ago 69% | 4 days ago 38% |
| Advances ODDS (%) | 4 days ago 69% | 7 days ago 67% |
| Declines ODDS (%) | 17 days ago 52% | 5 days ago 39% |
| BollingerBands ODDS (%) | 4 days ago 39% | 4 days ago 89% |
| Aroon ODDS (%) | 4 days ago 76% | 4 days ago 73% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBSC | 68.17 | 0.57 | +0.85% |
| JPMorgan BetaBuilders US Sml Cp Eq ETF | |||
| IJS | 103.78 | 0.40 | +0.39% |
| iShares S&P Small-Cap 600 Value ETF | |||
| ZTRE | 50.88 | N/A | N/A |
| F/M 3-Yr Invmt Grd Corp Bd ETF | |||
| SCDS | 55.13 | N/A | N/A |
| JPMorgan Fundamental Data Sci Sm Cor ETF | |||
| KSTR | 13.55 | N/A | -0.01% |
| KraneShares SSE STAR Market 50 ETF | |||
LLY and
Correlation & Price change
A.I.dvisor indicates that over the last year, LLY has been loosely correlated with AZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then AZN could also see price increases.